Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women

• Status: Completed
• Trial end date: 2020-10-10
• Target enrollment: 0
• Participant gender: Female

Summary

Postpartum hemorrhage and its complications are very well known causes for maternal mortality .Uterine atony is the most common cause for postpartum hemorrhage

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hawler Medical University
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Age ≥ 18 year.

• Planed vaginal delivery

• Grand multiparity

• Twin pregnancy

• Polyhydramnios

• Previous history of PPH

• Macrosomic baby

• Prolonged labour

• HELLP syndrome

• Using of low-molecular weight heparin and Asprin during pregnancy.

• Vaginal birth after Cesarean section

Exclusion Criteria:

• Intrauterine death.

• History of thromboembolic disease

• Current or previous history of heart disease ,renal and liver disorders

• History of seizure or epilepsy

• Placenta previa

• Placental abruptio